MCID: PYL004
MIFTS: 37

Pyelitis

Categories: Nephrological diseases

Aliases & Classifications for Pyelitis

MalaCards integrated aliases for Pyelitis:

Name: Pyelitis 12 44 15 73

Classifications:



External Ids:

Disease Ontology 12 DOID:2744
ICD10 33 N12
MeSH 44 D011702
NCIt 50 C34964
SNOMED-CT 68 197780007 27174002
UMLS 73 C0034183

Summaries for Pyelitis

MalaCards based summary : Pyelitis is related to pyelonephritis and urethritis. An important gene associated with Pyelitis is NEXMIF (Neurite Extension And Migration Factor). The drugs Cefixime and Ceftriaxone have been mentioned in the context of this disorder. Affiliated tissues include kidney, liver and spleen, and related phenotypes are homeostasis/metabolism and immune system

Wikipedia : 76 Pyelonephritis is inflammation of the kidney, typically due to a bacterial infection. Symptoms most... more...

Related Diseases for Pyelitis

Diseases related to Pyelitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 169)
# Related Disease Score Top Affiliating Genes
1 pyelonephritis 30.9 CRP CXCR1 TLR4
2 urethritis 30.2 CD40LG CD79A
3 pneumonia 29.6 CD40LG CRP TLR4
4 intestinal tuberculosis 10.8 CD79A CRP
5 sclerosing keratitis 10.7 B2M CD79A
6 amyloidosis aa 10.6 B2M CRP
7 rapidly progressive glomerulonephritis 10.6 CD79A CRP
8 spondylarthropathy 10.6 B2M TLR4
9 arteriolosclerosis 10.6 CD79A REN
10 dental abscess 10.6 CRP TLR4
11 acalculous cholecystitis 10.6 CD40LG CRP
12 mononeuritis multiplex 10.5 CD40LG CRP
13 selective igg deficiency disease 10.5 CD40LG CD79A
14 c1q nephropathy 10.5 CD40LG CD79A
15 meningovascular neurosyphilis 10.5 CD40LG CD79A
16 alpha chain disease 10.5 CD40LG CD79A
17 brill-zinsser disease 10.5 CD40LG CD79A
18 exudative glomerulonephritis 10.5 CD40LG CD79A
19 cork-handlers' disease 10.5 CD40LG CD79A
20 salpingo-oophoritis 10.5 CD40LG CD79A
21 early yaws 10.5 CD40LG CD79A
22 ventilation pneumonitis 10.5 CD40LG CD79A
23 chronic interstitial cystitis 10.5 CD40LG CD79A
24 axillary adenitis 10.5 CD40LG CD79A
25 cryofibrinogenemia 10.5 CD40LG CD79A
26 trichostrongyloidiasis 10.5 CD40LG CD79A
27 subacute bacterial endocarditis 10.5 CD40LG CD79A
28 heterophyiasis 10.5 CD40LG CD79A
29 immunoglobulin g deficiency 10.5 CD40LG CD79A
30 orbital granuloma 10.5 CD40LG CD79A
31 transient hypogammaglobulinemia of infancy 10.5 CD40LG CD79A
32 diverticulitis 10.5 CRP PKDREJ
33 hyperglobulinemic purpura 10.5 CD40LG CD79A
34 bacterial conjunctivitis 10.5 CD40LG CD79A
35 japanese spotted fever 10.5 CD40LG CRP
36 heavy chain disease 10.5 CD40LG CD79A
37 ophthalmia neonatorum 10.5 CD40LG CD79A
38 amyloid tumor 10.5 B2M CD79A PKDREJ
39 immunoglobulin a deficiency 1 10.5 CD40LG CD79A
40 parotid disease 10.5 CD40LG CD79A
41 cystitis 10.5
42 cerebral arteritis 10.5 CD40LG CD79A
43 selective immunoglobulin deficiency disease 10.5 CD40LG CD79A
44 geniculate herpes zoster 10.5 CD40LG CD79A
45 erythema elevatum diutinum 10.5 CD40LG CD79A
46 sporotrichosis 10.5 CD40LG CD79A
47 fallopian tube disease 10.5 CD40LG CD79A
48 hyperimmunoglobulin syndrome 10.5 CD40LG CD79A
49 congenital syphilis 10.5 CD40LG CD79A
50 polyclonal hypergammaglobulinemia 10.5 CD40LG CD79A

Graphical network of the top 20 diseases related to Pyelitis:



Diseases related to Pyelitis

Symptoms & Phenotypes for Pyelitis

MGI Mouse Phenotypes related to Pyelitis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.85 TLR4 B2M CD40LG CD79A CHRM3 CRP
2 immune system MP:0005387 9.61 B2M CD40LG CD79A CPN1 CRP CXCR1
3 renal/urinary system MP:0005367 9.1 TLR4 CD40LG CD79A CHRM3 LYZ REN

Drugs & Therapeutics for Pyelitis

Drugs for Pyelitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 94)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cefixime Approved, Investigational Phase 4 79350-37-1 54362 5362065
2
Ceftriaxone Approved Phase 4 73384-59-5 5479530 5361919
3
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 85721-33-1 2764
4
Levofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 100986-85-4 149096
5
Ofloxacin Approved Phase 4,Phase 3,Phase 2 82419-36-1 4583
6
Nitrofurantoin Approved, Vet_approved Phase 4,Phase 3 67-20-9 5353830
7
Sulfamethoxazole Approved Phase 4,Phase 3 723-46-6 5329
8
Trimethoprim Approved, Vet_approved Phase 4,Phase 3 738-70-5 5578
9
Amoxicillin Approved, Vet_approved Phase 4,Phase 3 26787-78-0 33613
10
Cephalexin Approved, Investigational, Vet_approved Phase 4 15686-71-2 27447
11
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3 59-30-3 6037
12
leucovorin Approved, Nutraceutical Phase 4,Phase 3 58-05-9 143 6006
13 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Not Applicable
14 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Not Applicable
15 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Not Applicable
16 Antitubercular Agents Phase 4,Phase 3,Not Applicable
17 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2
18 Fluoroquinolones Phase 4,Phase 2
19 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 2
20 Cytochrome P-450 CYP1A2 Inhibitors Phase 4,Phase 3,Phase 2
21 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 2
22 Renal Agents Phase 4,Phase 3,Phase 2
23 Antimalarials Phase 4,Phase 3
24 Antiparasitic Agents Phase 4,Phase 3
25 Antiprotozoal Agents Phase 4,Phase 3
26 Folic Acid Antagonists Phase 4,Phase 3
27 Trimethoprim, Sulfamethoxazole Drug Combination Phase 4,Phase 3
28 Vitamin B Complex Phase 4,Phase 3
29 Amdinocillin Pivoxil Phase 4
30 Folate Nutraceutical Phase 4,Phase 3
31 Vitamin B9 Nutraceutical Phase 4,Phase 3
32
Fosfomycin Approved Phase 2, Phase 3 23155-02-4 446987
33
Piperacillin Approved Phase 2, Phase 3,Phase 3 66258-76-2 43672
34
Tazobactam Approved Phase 2, Phase 3,Phase 3 89786-04-9 123630
35
Meropenem Approved, Investigational Phase 3,Phase 2 119478-56-7 64778 441130
36 Avibactam Approved Phase 3 1192500-31-4
37
Ceftazidime Approved Phase 3,Phase 2 78439-06-2, 72558-82-8 5481173
38
Colistin Approved Phase 3 1264-72-8, 1066-17-7 5311054
39
Minocycline Approved, Investigational Phase 3 10118-90-8 5281021
40
Tigecycline Approved Phase 3 220620-09-7 5282044
41
Cefepime Approved, Investigational Phase 3 88040-23-7 5479537
42
Ceftibuten Approved, Investigational Phase 3 97519-39-6 5282241 5282242
43 beta-Lactamase Inhibitors Phase 2, Phase 3,Phase 3
44 Penicillanic Acid Phase 2, Phase 3,Phase 3
45 Piperacillin, tazobactam drug combination Phase 2, Phase 3,Phase 3
46 Ceftolozane, tazobactam drug combination Phase 3,Phase 2
47 Cephalosporins Phase 3,Phase 2
48 Thienamycins Phase 3,Phase 2
49 Avibactam, ceftazidime drug combination Phase 3
50 Pharmaceutical Solutions Phase 3,Phase 2,Not Applicable

Interventional clinical trials:

(show top 50) (show all 55)
# Name Status NCT ID Phase Drugs
1 Efficacy and Safety Study of Short-term Antibiotic for Pyelonephritis in Women Completed NCT01390623 Phase 4 Ceftriaxone
2 Treatment of Acute Pyelonephritis With Gram Negative Strains in Infants and Children Less Than 3 Years Old Completed NCT00136656 Phase 4 antibiotic;antibiotics
3 Pharmacokinetics of Ciprofloxacin in Pediatric Patients Completed NCT02598362 Phase 4 ciprofloxacin
4 Treatment's Duration of Acute Uncomplicated Pyelonephritis Completed NCT00873626 Phase 4 levofloxacin, ciprofloxacin and ofloxacin (fluoroquinolones)
5 A Randomized Controlled Trial on Antibiotic Prophylaxis in Children With Vesico-Ureteral Reflux Completed NCT00382343 Phase 4 Sulfamethoxazole/trimethoprim
6 Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication Completed NCT02246361 Phase 4
7 Impact on the Intestinal Microbiota of Treatment With Ceftriaxone in Women's Acute Community Pyelonephritis Recruiting NCT03179384 Phase 4 Ceftriaxone
8 Treating Pyelonephritis an Urosepsis With Pivmecillinam Recruiting NCT03282006 Phase 4 pivmecillinam
9 Management of Sub-Clinical Bacteriuria in Pregnancy Recruiting NCT03275623 Phase 4 Antibiotic
10 Safety and Efficacy Study of the Treatment of Kidney Infections With Short Course Levofloxacin Terminated NCT00239161 Phase 4 Levofloxacin
11 Oral Omega-3 for Reduction of Kidney Scar Due to Pyelonephritis in Children Unknown status NCT02192580 Phase 3 Omega-3
12 L-carnitine on the Prevention of Renal Scarring in Acute Pyelonephritis Unknown status NCT02007889 Phase 3 L-carnitine
13 CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria Completed NCT03477422 Phase 3 CSE-1034 (Ceftriaxone + Sulbactam + EDTA);Meropenem
14 Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections Completed NCT02753946 Phase 2, Phase 3 ZTI-01;Piperacillin-tazobactam
15 Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014) Completed NCT02728089 Phase 3 MK-7625A 1.5 g (ceftolozane 1 g/tazobactam 0.5 g)
16 A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP) Completed NCT02486627 Phase 3 plazomicin;meropenem;levofloxacin (oral)
17 Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP Completed NCT02166476 Phase 3 Meropenem-Vaborbactam;Piperacillin-Tazobactam;Levofloxacin;Saline
18 Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections) Completed NCT01599806 Phase 3 Ceftazidime - Avibactam ( CAZ-AVI);Doripenem;Either switch to oral therapy: 500 mg of Ciprofloxacin (oral);or switch to oral therapy: 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral)
19 Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections) Completed NCT01595438 Phase 3 Ceftazidime - Avibactam ( CAZ-AVI);Doripenem;Either switch to oral therapy: 500 mg of Ciprofloxacin (oral);or switch to oral therapy: 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral)
20 Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis Completed NCT01345929 Phase 3 CXA-201;Levofloxacin
21 Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis Completed NCT00229021 Phase 3 doripenum
22 Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis Completed NCT00210990 Phase 3 doripenem
23 A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis. Completed NCT00210886 Phase 3 levofloxacin
24 Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults Completed NCT02168946 Phase 3 Vabomere;Best Available Therapy
25 A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE) Completed NCT01970371 Phase 3 plazomicin;colistin;meropenem;tigecycline;antibiotic of Investigator's choice
26 A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections Completed NCT00258089 Phase 3 Levofloxacin
27 A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections Terminated NCT01110408 Phase 3 Doripenem;Doripenem placebo;Cefepime;Cefepime placebo;Amoxicillin/clavulanate potassium
28 Short-term Antibiotic Therapy for Pyelonephritis in Childhood Terminated NCT00724256 Phase 3 ceftibuten;ceftibuten
29 Antibiotic Prophylaxis in Children With Pyelonephritis Withdrawn NCT00752375 Phase 3 Trimethoprim Sulfamethoxazole;placebo
30 Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli Unknown status NCT02537847 Phase 2 Sitafloxacin;Ertapenem
31 Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults With Complicated Urinary Tract Infections Completed NCT03445195 Phase 2 Sulbactam-ETX2514;Placebo;Imipenem-cilastatin
32 A Study of Efficacy/Safety of Intravenous S-649266 Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections Completed NCT02321800 Phase 2 S-649266;Imipenem/cilastatin
33 Effect of Acetylcysteine in Pediatric Acute Pyelonephritis. Completed NCT02080182 Phase 2 Acetylcysteine;placebo acetylcysteine
34 Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003) Completed NCT01505634 Phase 2 MK-7655 250 mg;MK-7655 125 mg;imipenem/cilastatin 500 mg;Placebo to MK-7655;Ciprofloxacin
35 Study of Plazomicin (ACHN-490) Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis Completed NCT01096849 Phase 2 levofloxacin;plazomicin;placebo
36 Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections Completed NCT00921024 Phase 2 CXA-101;Ceftazidime
37 Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis Completed NCT01928433 Phase 2 Finafloxacin 800 mg i.v. once daily;Finafloxacin placebo i.v. once daily;Finafloxacin 800 mg tablets once daily;Finafloxacin placebo tablets once daily;Ciprofloxacin 400 mg i.v. twice daily;Ciprofloxacin placebo i.v. twice daily;Ciprofloxacin 500 mg oral twice daily;Ciprofloxacin placebo oral twice daily
38 MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034) Recruiting NCT03230838 Phase 2 Ceftolozane;Tazobactam;Meropenem
39 GSK2251052 in Complicated Urinary Tract Infection Terminated NCT01381549 Phase 2 GSK2251052;imipenem-cilastatin
40 Prospective Study in the Emergency Terminated NCT01628900 Phase 2
41 Dexamethasone Administration in 1st Episode of Febrile Urinary Tract Infection Unknown status NCT02034851
42 Antibiotic Treatment Versus no Therapy in Kidney Transplant Recipients With Asymptomatic Bacteriuria Unknown status NCT01771432 Not Applicable Antibiotic treatment
43 Proteinuria During Acute Pyelonephritis In Pregnancy Unknown status NCT02536638
44 Contrast-Enhanced US of Spleen, Liver and Kidney Unknown status NCT00190281
45 Kinetics of Biomarkers in Acute Pyelonephritis Completed NCT00805181
46 Risk Factors for Recurrent Urinary Tract Infection in Children Completed NCT00528476
47 Prospective Comparative Study About Treatment of Asymptomatic Bacteriuria in Kidney Transplant Recipients. Completed NCT02373085 Not Applicable
48 Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae Completed NCT02420366
49 Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis Completed NCT01641029
50 Prognostic Indicators as Provided by the EPIC ClearView Completed NCT01476995

Search NIH Clinical Center for Pyelitis

Cochrane evidence based reviews: pyelitis

Genetic Tests for Pyelitis

Anatomical Context for Pyelitis

MalaCards organs/tissues related to Pyelitis:

41
Kidney, Liver, Spleen, Colon

Publications for Pyelitis

Articles related to Pyelitis:

(show top 50) (show all 150)
# Title Authors Year
1
Air bubbles in the urinary tract. Incidental and asymptomatic combined emphysematous pyelitis, ureteritis and cystitis. A rare case report and review of the literature. ( 29785361 )
2018
2
Foley Follies: Emphysematous Pyelitis from Instrumentation in Obstructive Uropathy. ( 29098124 )
2017
3
Emphysematous Pyelitis: An Entity Distinct from Emphysematous Pyelonephritis. ( 28502342 )
2017
4
Emphysematous pyelitis and cystitis associated with vesicoureteral reflux in a diabetic dog. ( 27041755 )
2016
5
Pseudotuberculous Granulomatous Pyelitis: Report of a Case. ( 27440812 )
2016
6
Encrusted Uretero-pyelitis: Case Report. ( 27335796 )
2016
7
Appearance of Pyelitis Emphysematosa on Computed Tomography. ( 27993715 )
2016
8
Emphysematous cystitis with concomitant bilateral emphysematous ureteritis and pyelitis in a diabetic patient. ( 26175815 )
2015
9
"I have chicken fat in my urine!" A case of Candida tropicalis induced emphysematous pyelitis. ( 26909246 )
2015
10
Plagiarism in the article Emphysematous cystitis and emphysematous pyelitis: a clinically misleading association. Mustapha Ahsaini et al. The Pan African Medical Journal. 2013;16:18. (doi:10.11604/pamj.2013.16.18.2505). ( 26328003 )
2015
11
67Ga SPECT/CT of infected bladder stones and pyelitis. ( 25546213 )
2015
12
A Rare Case of Pneumoureter: Emphysematous Pyelitis versus Emphysematous Pyelonephritis. ( 26676155 )
2015
13
Emphysematous Pyelitis. ( 25266345 )
2014
14
Ileo-pelvic anastomosis and augmentation cystoplasty for treatment of encrusted pyelitis in a transplanted kidney. ( 23550263 )
2013
15
Bilateral emphysematous pyelitis: a rare encounter in urology. ( 24045515 )
2013
16
Emphysematous cystitis and emphysematous pyelitis: a clinically misleading association. ( 24498467 )
2013
17
Encrusted cystitis and pyelitis. ( 22616968 )
2012
18
Emphysematous urinoma as a complication of emphysematous pyelitis in a healthy adult male. ( 22739565 )
2012
19
Clinics in diagnostic imaging (138). Emphysematous pyelitis. ( 22434298 )
2012
20
Case 167: alkaline-encrusted pyelitis. ( 21339355 )
2011
21
Alkaline-encrusted pyelitis and cystitis: an easily missed and life-threatening urinary infection. ( 22700348 )
2011
22
Emphysematous pyelitis. ( 20231336 )
2010
23
Emphysematous pyelitis, ureteritis and cystitis. ( 21749809 )
2010
24
Emphysematous pyelitis. ( 20231342 )
2010
25
Chronic sclerosing pyelitis with an increased number of IgG4-positive plasma cells. ( 20033370 )
2009
26
Emphysematous pyelitis: epidemiological, therapeutic and evolutive features. ( 19537009 )
2009
27
Air in the kidney: between emphysematous pyelitis and pyelonephritis. ( 21611013 )
2008
28
Granulomatous pyelitis associated with urinary obstruction: a comprehensive clinicopathologic study. ( 16715072 )
2006
29
Alkaline encrusted pyelitis. ( 16502598 )
2005
30
Monolateral encrusted pyelitis in a double kidney transplanted patient. ( 15931651 )
2005
31
Encrusted cystitis and pyelitis in children: an unusual condition with potentially severe consequences. ( 15592084 )
2005
32
Successful treatment of encrusted cystitis and pyelitis with preservation of renal graft. ( 15280698 )
2004
33
Encrusted cystitis and pyelitis in children: an unusual condition with potentially severe consequences. ( 15351595 )
2004
34
Renal pelvic wall thickening in childhood urinary tract infections--evidence of acute pyelitis or vesicoureteral reflux? ( 12745739 )
2003
35
Bilharzial pyelitis: a rare cause of secondary ureteropelvic junction obstruction. ( 14532820 )
2003
36
Mortality from grossly encrusted bilateral pyelitis, ureteritis, and cystitis by Corynebacterium group D2. ( 12597981 )
2003
37
Emphysematous pyelitis presenting as an acute abdomen in an end-stage renal disease patient treated with peritoneal dialysis. ( 14558537 )
2003
38
Emphysematous pyelitis presenting as an acute abdomen in an end-stage renal disease patient treated with peritoneal dialysis. ( 12324934 )
2002
39
ED ultrasound: emphysematous pyelitis. ( 12098188 )
2002
40
Imaging characteristics of alkaline-encrusted cystitis and pyelitis. ( 11804900 )
2002
41
Encrusted cystitis and pyelitis. ( 11306884 )
2001
42
Emphysematous pyelitis: findings in five patients. ( 11230634 )
2001
43
Renal scan in emphysematous pyelitis. ( 11711715 )
2001
44
Encrusted pyelitis: an underdiagnosed condition? ( 10862627 )
2000
45
Hemorrhagic pyelitis, ureteritis, and cystitis secondary to cyclophosphamide: case report and review of the literature. ( 10637075 )
2000
46
Encrusted pyelitis of native kidneys. ( 10820179 )
2000
47
The conservative management of corynebacterium group D2 encrusted pyelitis. ( 10468720 )
1999
48
Successful treatment of encrusted pyelitis in a renal transplant with local acidification and surgical ileocaliceal anastomosis. ( 10492200 )
1999
49
Encrusted cystitis and pyelitis. ( 9628593 )
1998
50
Pyelitis cystica. ( 9406318 )
1997

Variations for Pyelitis

Expression for Pyelitis

Search GEO for disease gene expression data for Pyelitis.

Pathways for Pyelitis

GO Terms for Pyelitis

Cellular components related to Pyelitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 8.92 B2M CD40LG CD79A TLR4

Biological processes related to Pyelitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of interleukin-12 production GO:0032735 9.16 CD40LG TLR4
2 positive regulation of interleukin-10 production GO:0032733 8.96 CD40LG TLR4
3 inflammatory response GO:0006954 8.92 CD40LG CRP LYZ TLR4

Sources for Pyelitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....